Beyond Oil and Iran Consumer Prices Reaccelerate Across Multiple Sectors Viatris Inc Attracts Analyst Attention Amid Strategic Portfolio Shifts Jim Cramer Comments on What He Calls a Silly Aspect of Arm Holdings Stock Quantum Computing Stocks Rally on US Government Funding Big Tech Absence Raises Questions Lithuania Data Breach Exposes 600000 National Records Raising Cybersecurity Concerns Indian Equity Markets End Week Higher Amid USIran Diplomacy Focus QCLS Q4 2017 Earnings Massive EPS Miss Reflects Operational Challenges WFC Q1 2026 Earnings Modest EPS Beat Amidst Stable Performance KNTK Q1 2026 Earnings Significant EPS Miss as Company Posts Surprise Loss IZEA Q4 2025 Earnings EPS Misses Estimates as Stock Rises on Potential Turnaround LSI Industries LYTS Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance VNO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Office Market Entergy New Orleans LLC Bonds ENJ Edge Higher as Price Holds Near 1992 JELDWEN Holding Inc JELD Stages a Modest Recovery Navigating Support and Resistance Levels Installed Building Products Faces Headwinds Holds Above Key Support Levels Phio Pharmaceuticals PHIO Holds Steady at 109 as Stock Consolidates Between Key Levels Tencent Music Entertainment TME Drops 37 as Market Sentiment Weighs on Chinese Tech Stocks HDFC Bank Stock Weakness May Present Potential Opportunity for LongTerm Investors HIMS Q1 2026 Earnings EPS Misses Estimates Sharply as Stock Edges Higher Intellia Therapeutics NTLA Rebounds GeneEditing Stock Shows Promise Near Support Braemar Hotels Resorts Inc BHR Q1 2026 Earnings Massive EPS Surprise of 42178 Beats Estimates SWBI Q1 2026 Earnings EPS Surprises Despite Flat Market Reception RKDA Q3 2025 Earnings Massive EPS Surprise Driven by NonOperating Gains Revenue Still Absent Unity Software Q1 2026 Earnings Narrower Loss Beats Estimates Stock Edges Higher EPR Properties Q1 2026 Earnings EPS Beats Estimates by 11 as Experiential Portfolio Shows Resilience Abivax ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Costs SRPT Q1 2026 Earnings EPS Surges 18467 Above Estimates Amid Strong Gene Therapy Progress